Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study
Autor: | E, Hommel, B, Olsen, T, Battelino, I, Conget, I, Schütz-Fuhrmann, R, Hoogma, U, Schierloh, N, Sulli, H, Gough, J, Castañeda, S, de Portu, J, Bolinder, B, Shashaj |
---|---|
Rok vydání: | 2014 |
Předmět: |
Blood Glucose
Male medical resources Endocrinology Diabetes and Metabolism treatment satisfaction insulin pump therapy law.invention Indirect costs Endocrinology Quality of life Randomized controlled trial law Medicine Insulin Young adult Child Continuous glucose monitoring Multidisciplinary general & others [D99] [Human health sciences] Cross-Over Studies Incidence (epidemiology) Medicine (all) Hemoglobin A General Medicine Health Care Costs Middle Aged Diabetes and Metabolism Patient Satisfaction Original Article Type 1 Medical resources Adult medicine.medical_specialty Multidisciplinaire généralités & autres [D99] [Sciences de la santé humaine] Adolescent sensouraugmented insulin pump therapy Glycosylated Young Adult Insulin pump therapy Patient satisfaction Insulin Infusion Systems Diabetes Mellitus Internal Medicine Humans Hypoglycemic Agents Aged Glycated Hemoglobin Type 1 diabetes Treatment satisfaction business.industry Blood Glucose Self-Monitoring Sensor-augmented insulin pump therapy Diabetes Mellitus Type 1 Hemoglobin A Glycosylated Quality of Life medicine.disease Crossover study Surgery quality of life Physical therapy business |
Zdroj: | Acta Diabetologica Acta Diabetologica, 51(5), 845-851. Berlin, Germany: Springer Verlag (2014). |
ISSN: | 1432-5233 |
Popis: | To investigate the impact of continuous glucose monitoring (CGM) on health-related quality of life (HRQOL), treatment satisfaction (TS) medical resource use, and indirect costs in the SWITCH study. SWITCH was a multicentre, randomized, crossover study. Patients with type 1 diabetes (n = 153) using continuous subcutaneous insulin infusion (CSII) were randomized to a 12 month sensor-On/Off or sensor-Off/On sequence (6 months each treatment), with a 4-month washout between periods. HRQOL in children and TS in adults were measured using validated questionnaires. Medical resource utilization data were collected. In adults, TS was significantly higher in the sensor-On arm, and there were significant improvements in ratings for treatment convenience and flexibility. There were no clinically significant differences in children’s HRQOL or parents’ proxy ratings. The incidence of severe hypoglycaemia, unscheduled visits, or diabetes-related hospitalizations did not differ significantly between the two arms. Adult patients made fewer telephone consultations during the sensor-On arm; children’s caregivers made similar numbers of telephone consultations during both arms, and calls were on average only 3 min longer during the sensor-On arm. Regarding indirect costs, children with >70 % sensor usage missed fewer school days, compared with the sensor-Off arm (P = 0.0046) but there was no significant difference in the adults days of work off. The addition of CGM to CSII resulted in better metabolic control without imposing an additional burden on the patient or increased medical resource use, and offered the potential for cost offsets. |
Databáze: | OpenAIRE |
Externí odkaz: |